Skip to main content
NCBI home page
The BMJ logoLink to The BMJ
editorial
. 1990 Sep 22;301(6752):564–565. doi: 10.1136/bmj.301.6752.564

Acid suppression: how much is needed?

D G Colin-Jones
PMCID: PMC1663749  PMID: 1978697

Full text

PDF
564

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Burlinson B., Morriss S. H., Gatehouse D. G., Tweats D. J. Genotoxicity studies of gastric acid inhibiting drugs. Lancet. 1990 Feb 17;335(8686):419–420. doi: 10.1016/0140-6736(90)90260-c. [DOI] [PubMed] [Google Scholar]
  2. Chiverton S. G., Hunt R. H. Medical regimens in short- and long-term ulcer management. Baillieres Clin Gastroenterol. 1988 Jul;2(3):655–676. doi: 10.1016/s0950-3528(88)80012-5. [DOI] [PubMed] [Google Scholar]
  3. Colin-Jones D. G. Histamine-2-receptor antagonists in gastro-oesophageal reflux. Gut. 1989 Oct;30(10):1305–1308. doi: 10.1136/gut.30.10.1305. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Dobrilla G., Comberlato M., Steele A., Vallaperta P. Drug treatment of functional dyspepsia. A meta-analysis of randomized controlled clinical trials. J Clin Gastroenterol. 1989 Apr;11(2):169–177. doi: 10.1097/00004836-198904000-00011. [DOI] [PubMed] [Google Scholar]
  5. Havelund T., Laursen L. S., Skoubo-Kristensen E., Andersen B. N., Pedersen S. A., Jensen K. B., Fenger C., Hanberg-Sørensen F., Lauritsen K. Omeprazole and ranitidine in treatment of reflux oesophagitis: double blind comparative trial. Br Med J (Clin Res Ed) 1988 Jan 9;296(6615):89–92. doi: 10.1136/bmj.296.6615.89. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Howden C. W., Hunt R. H. The relationship between suppression of acidity and gastric ulcer healing rates. Aliment Pharmacol Ther. 1990 Feb;4(1):25–33. doi: 10.1111/j.1365-2036.1990.tb00445.x. [DOI] [PubMed] [Google Scholar]
  7. Ireland A., Colin-Jones D. G., Gear P., Golding P. L., Ramage J. K., Williams J. G., Leicester R. J., Smith C. L., Ross G., Bamforth J. Ranitidine 150 mg twice daily vs 300 mg nightly in treatment of duodenal ulcers. Lancet. 1984 Aug 4;2(8397):274–276. doi: 10.1016/s0140-6736(84)90312-x. [DOI] [PubMed] [Google Scholar]
  8. Joelsson B., Johnsson F. Heartburn--the acid test. Gut. 1989 Nov;30(11):1523–1525. doi: 10.1136/gut.30.11.1523. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Klinkenberg-Knol E. C., Jansen J. M., Festen H. P., Meuwissen S. G., Lamers C. B. Double-blind multicentre comparison of omeprazole and ranitidine in the treatment of reflux oesophagitis. Lancet. 1987 Feb 14;1(8529):349–351. doi: 10.1016/s0140-6736(87)91726-0. [DOI] [PubMed] [Google Scholar]
  10. Lanzon-Miller S., Pounder R. E., Hamilton M. R., Chronos N. A., Ball S., Mercieca J. E., Olausson M., Cederberg C. Twenty-four-hour intragastric acidity and plasma gastrin concentration in healthy subjects and patients with duodenal or gastric ulcer, or pernicious anaemia. Aliment Pharmacol Ther. 1987 Jun;1(3):225–237. doi: 10.1111/j.1365-2036.1987.tb00622.x. [DOI] [PubMed] [Google Scholar]
  11. Larsson H., Carlsson E., Mattsson H., Lundell L., Sundler F., Sundell G., Wallmark B., Watanabe T., Håkanson R. Plasma gastrin and gastric enterochromaffinlike cell activation and proliferation. Studies with omeprazole and ranitidine in intact and antrectomized rats. Gastroenterology. 1986 Feb;90(2):391–399. doi: 10.1016/0016-5085(86)90938-8. [DOI] [PubMed] [Google Scholar]
  12. Lee F. I., Booth S. N., Cochran K. M., Crowe J., Dickinson R. J., Kennedy N. P., Cottrell J., Mann S. G. Single night-time doses of 40 mg famotidine or 800 mg cimetidine in the treatment of duodenal ulcer. Aliment Pharmacol Ther. 1989 Oct;3(5):505–512. doi: 10.1111/j.1365-2036.1989.tb00242.x. [DOI] [PubMed] [Google Scholar]
  13. Lloyd-Davies K. A., Rutgersson K., Sölvell L. Omeprazole in the treatment of Zollinger-Ellison syndrome: a 4-year international study. Aliment Pharmacol Ther. 1988 Feb;2(1):13–32. doi: 10.1111/j.1365-2036.1988.tb00667.x. [DOI] [PubMed] [Google Scholar]
  14. Management of dyspepsia: report of a working party. Lancet. 1988 Mar 12;1(8585):576–579. [PubMed] [Google Scholar]
  15. McIsaac R. L., McCanless I., Summers K., Wood J. R. Ranitidine and cimetidine in the healing of duodenal ulcer: meta-analysis of comparative clinical trials. Aliment Pharmacol Ther. 1987 Oct;1(5):369–381. doi: 10.1111/j.1365-2036.1987.tb00637.x. [DOI] [PubMed] [Google Scholar]
  16. Merki H. S., Halter F., Wilder-Smith C., Allemann P., Witzel L., Kempf M., Roehmel J., Walt R. P. Effect of food on H2-receptor blockade in normal subjects and duodenal ulcer patients. Gut. 1990 Feb;31(2):148–150. doi: 10.1136/gut.31.2.148. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Merki H., Witzel L., Harre K., Scheurle E., Neumann J., Röhmel J. Single dose treatment with H2 receptor antagonists: is bedtime administration too late? Gut. 1987 Apr;28(4):451–454. doi: 10.1136/gut.28.4.451. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Omeprazole and genotoxicity. Lancet. 1990 Apr 14;335(8694):909–911. [PubMed] [Google Scholar]
  19. Page M. C., Lacey L. A., Mills J. G., Wood J. R. Can higher doses of an H2-receptor antagonist accelerate duodenal ulcer healing? Aliment Pharmacol Ther. 1989 Oct;3(5):425–433. doi: 10.1111/j.1365-2036.1989.tb00233.x. [DOI] [PubMed] [Google Scholar]
  20. Soll A. H. Review: antisecretory drugs: cellular mechanisms of action. Aliment Pharmacol Ther. 1987 Apr;1(2):77–89. doi: 10.1111/j.1365-2036.1987.tb00609.x. [DOI] [PubMed] [Google Scholar]

Articles from BMJ : British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES